207 related articles for article (PubMed ID: 27980401)
1. Effects of aclidinium on determinants of COPD severity: symptoms and quality of life.
Contoli M; Solidoro P; Di Marco F; Scichilone N; Corsico A; Braido F; Santus P
Int J Chron Obstruct Pulmon Dis; 2016; 11():3043-3050. PubMed ID: 27980401
[TBL] [Abstract][Full Text] [Related]
2. Clinical potential of aclidinium bromide in chronic obstructive pulmonary disease.
Jones PW
Int J Chron Obstruct Pulmon Dis; 2015; 10():677-87. PubMed ID: 25848244
[TBL] [Abstract][Full Text] [Related]
3. The potential for aclidinium bromide, a new anticholinergic, in the management of chronic obstructive pulmonary disease.
Maltais F; Milot J
Ther Adv Respir Dis; 2012 Dec; 6(6):345-61. PubMed ID: 23075544
[TBL] [Abstract][Full Text] [Related]
4. Profile of aclidinium bromide in the treatment of chronic obstructive pulmonary disease.
Sims MW; Panettieri RA
Int J Chron Obstruct Pulmon Dis; 2011; 6():457-66. PubMed ID: 22003291
[TBL] [Abstract][Full Text] [Related]
5. Clinicopharmacological profile of the fixed-dose combination of aclidinium bromide and formoterol fumarate in the management of chronic obstructive pulmonary disease.
Babu KS; Morjaria JB
Ther Adv Respir Dis; 2015 Apr; 9(2):56-68. PubMed ID: 25754881
[TBL] [Abstract][Full Text] [Related]
6. A Real-World Observational Study Examining the Impact of Aclidinium Bromide Therapy on the Quality of Life, Symptoms, and Activity Impairment of Patients with Chronic Obstructive Pulmonary Disease: The Greek ON-AIR Study.
Kostikas K; Vassilakopoulos TI; Tzanakis N; Konstantinidis AK; Kosmas EN; Papiris S; Steiropoulos P; Manali ED; Michaelides SA; Daskos G
Int J Chron Obstruct Pulmon Dis; 2020; 15():515-526. PubMed ID: 32184588
[TBL] [Abstract][Full Text] [Related]
7. Clinical use of aclidinium in patients with COPD.
Reid DJ; Carlson AA
Int J Chron Obstruct Pulmon Dis; 2014; 9():369-79. PubMed ID: 24812502
[TBL] [Abstract][Full Text] [Related]
8. Effects of Adding Tiotropium or Aclidinium as Triple Therapy Using Impulse Oscillometry in COPD.
Manoharan A; Morrison AE; Lipworth BJ
Lung; 2016 Apr; 194(2):259-66. PubMed ID: 26758884
[TBL] [Abstract][Full Text] [Related]
9. [Aclidinium bromide improves the lung function and reduces dyspnoea in patients with COPD].
Ulrik CS
Ugeskr Laeger; 2014 Jul; 176(28):V01130052. PubMed ID: 25291997
[TBL] [Abstract][Full Text] [Related]
10. Aclidinium bromide inhalation powder for the long-term, maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease including chronic bronchitis and emphysema.
Matera MG; Sanduzzi A; Alfano R; Cazzola M
Expert Rev Clin Pharmacol; 2016 Jun; 9(6):771-7. PubMed ID: 26998725
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and Safety of an Aclidinium Bromide Treatment for 12 Weeks or Longer in Patients with Moderate-To-Severe COPD: A Meta-Analysis.
Zou Y; Xiao J; Yang DH; Li J; Chen Q
COPD; 2016 Aug; 13(4):499-508. PubMed ID: 26846588
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of aclidinium bromide 400 μg twice daily compared with placebo and tiotropium in patients with moderate to severe COPD.
Fuhr R; Magnussen H; Sarem K; Llovera AR; Kirsten AM; Falqués M; Caracta CF; Garcia Gil E
Chest; 2012 Mar; 141(3):745-752. PubMed ID: 21903737
[TBL] [Abstract][Full Text] [Related]
13. New opportunities of dual bronchodilation therapy for patients with chronic obstructive pulmonary disease.
Avdeev SN; Trushenko NV
Ter Arkh; 2019 Mar; 91(3):76-85. PubMed ID: 31094464
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of a 12-week treatment with twice-daily aclidinium bromide in COPD patients (ACCORD COPD I).
Kerwin EM; D'Urzo AD; Gelb AF; Lakkis H; Garcia Gil E; Caracta CF;
COPD; 2012 Apr; 9(2):90-101. PubMed ID: 22320148
[TBL] [Abstract][Full Text] [Related]
15. Aclidinium bromide for the treatment of chronic obstructive pulmonary disease.
Gupta V; Singh D
Expert Rev Respir Med; 2012 Dec; 6(6):581-8. PubMed ID: 23234445
[TBL] [Abstract][Full Text] [Related]
16. Long-acting antimuscarinic therapy in patients with chronic obstructive pulmonary disease receiving beta-blockers.
Chapman KR; Wise RA; Scirica BM; Bhatt DL; Daoud SZ; Lythgoe D; Gil EG
Respir Res; 2021 Oct; 22(1):272. PubMed ID: 34686204
[TBL] [Abstract][Full Text] [Related]
17. The discovery and development of aclidinium bromide for the treatment of chronic obstructive pulmonary disease.
Malerba M; Radaeli A; Santini G; Morjaria J; Mores N; Mondino C; Macis G; Montuschi P
Expert Opin Drug Discov; 2018 Jun; 13(6):563-577. PubMed ID: 29616842
[TBL] [Abstract][Full Text] [Related]
18. Faster reduction in hyperinflation and improvement in lung ventilation inhomogeneity promoted by aclidinium compared to glycopyrronium in severe stable COPD patients. A randomized crossover study.
Santus P; Radovanovic D; Di Marco F; Raccanelli R; Valenti V; Centanni S
Pulm Pharmacol Ther; 2015 Dec; 35():42-9. PubMed ID: 26549785
[TBL] [Abstract][Full Text] [Related]
19. Aclidinium bromide for the treatment of chronic obstructive pulmonary disease.
Cazzola M; Page CP; Matera MG
Expert Opin Pharmacother; 2013 Jun; 14(9):1205-14. PubMed ID: 23566013
[TBL] [Abstract][Full Text] [Related]
20. Aclidinium bromide twice daily for the treatment of chronic obstructive pulmonary disease: a review.
Jones P
Adv Ther; 2013 Apr; 30(4):354-68. PubMed ID: 23553509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
